Eyes
ISTA Pharma says Xibrom QD eliminated eye inflammation and eye pain after cataract surgery
|
|
ISTA says daily Xibrom eye drops met goal in study
IRVINE, Calif. — ISTA Pharmaceuticals Inc. on Wednesday reported successful late-stage clinical trial results for Xibrom QD, a new once-per-day eye drug.
The company said Xibrom QD eye drops were significantly better than a placebo at eliminating eye inflammation 15 days after cataract surgery. The drug also
|
 |
| (Published: Wed, 26 Aug 2009 19:30:39 +0000) |
|
|
|
|